Oklahoma Heart Institute was the first in Oklahoma to implant the Medtronic Reveal LINQ Insertable Cardiac Monitoring System in two patients this week. This device is the smallest cardiac monitoring system available and is one-third the size of a AAA battery, making it 80 percent smaller than other implantable cardiac monitoring systems. This device allows physicians to continuously and wirelessly monitor patients up to three years. Physicians may also receive alerts sent directly to them if a patient is having a cardiac event. This device may be recommended for patients who experience symptoms such as dizziness, palpitations, fainting, other symptoms that may suggest a cardiac arrhythmia, or patients who are at-risk for an arrhythmia. Dr. David Sandler, cardiac electrophysiologist, shares more in this video.